2,3,6-trimethyl-1,2,4-triazin-5(2H)-one | 39070-04-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三嗪类
• 英文名称: 2,3,6-trimethyl-1,2,4-triazin-5(2H)-one
• 英文别名: 2,3,6-Trimethyl-2,5-dihydro-5-oxo-1,2,4-triazin；2,3,6-trimethyl-2H-[1,2,4]triazin-5-one；2,3,6-Trimethyl-1,2,4-triazin-5-one
• CAS: 39070-04-7
• 化学式: C₆H₉N₃O
• 分子量: 139.157
• InChiKey: XQDKURSEZKPMSX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  45
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-(2,6-dimethyl-2,5-dihydro-5-oxo-1,2,4-triazin-3-yl)acetamide 、 sodium hydroxide 以28%的产率得到
  参考文献：
  名称：

  STYLES, V. L.;MORRISON, R. W. ,, JR., J. ORG. CHEM., 1985, 50, N 3, 346-350

  摘要：

  DOI：

文献信息

• Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections
  申请人：SOMMADOSSI Jean-Pierre

  公开号：US20090238790A2

  公开（公告）日：2009-09-24

  Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.

  本文提供了用于治疗肝脏疾病，包括HCV和/或HBV感染的化合物、组合物和方法。具体来说，披露了核苷衍生物的化合物和组合物，可以单独或与其他抗病毒药物联合使用。
• Compounds and pharmaceutical compositions for the treatment of viral infections
  申请人：Sommadossi Jean-Pierre

  公开号：US20080286230A1

  公开（公告）日：2008-11-20

  Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.

  本文提供了用于治疗肝脏疾病，包括HCV和/或HBV感染的化合物、组合物和方法。具体地，本文公开了核苷衍生物的化合物和组合物，可以单独或与其他抗病毒药物联合使用。
• COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS
  申请人：SOMMADOSSI Jean-Pierre

  公开号：US20110286962A1

  公开（公告）日：2011-11-24

  Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.

  本文提供了治疗肝脏疾病，包括HCV和/或HBV感染的化合物、组合物和方法。具体地，揭示了核苷衍生物的化合物和组合物，可以单独或与其他抗病毒药物联合使用。
• Compounds and Pharmaceutical compositions for the treatment of Viral infections
  申请人：Sommadossi Jean-Pierre

  公开号：US20090169504A1

  公开（公告）日：2009-07-02

  Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.

  本文提供了用于治疗肝脏疾病，包括HCV和/或HBV感染的化合物，组合物和方法。具体地，公开了核苷衍生物的化合物和组合物，可以单独或与其他抗病毒药物联合使用。
• Pyrimido[4,5-c]pyridazines. 6. Pyrimido[4,5-c]pyridazines and 1,2,4-triazines from reactions between 6-hydrazinopyrimidin-4(3H)-ones and vicinal dicarbonyl reagents
  作者：Virgil L. Styles、Robert W. Morrison

  DOI：10.1021/jo00203a012

  日期：1985.2